Trials / Completed
CompletedNCT04043793
ICU-acquired Colonization and Infection Related to MDR in Immunocompromised Patients
Intensive Care Unit (ICU)-Acquired Colonization and Infection Related to Multidrug Resistant Bacteria (MDR) in Immunocompromised Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 759 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
the number of immunocompromised patients hospitalized in the intensive care units (ICU) is increasing. They are at higher risk of colonization and/or infection with multi-resistant bacteria (MDR). However this risk is not well characterized. ICU acquired infections related to MDR are associated with increased morbidity and mortality. The aim of this study is to compare the incidence of ICU-acquired colonization and ICU-acquired infection related to MDR between immunocompromized and immunocompetent patients. The risk factors for ICU-acquired colonization and ICU-acquired infections, and their impact on outcome will also be evaluated and compared between immunocompromised and immunocompetent patients.
Conditions
Timeline
- Start date
- 2019-11-07
- Primary completion
- 2021-12-07
- Completion
- 2021-12-07
- First posted
- 2019-08-02
- Last updated
- 2022-10-05
Locations
7 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04043793. Inclusion in this directory is not an endorsement.